Clinical Implications of “Tailored” Antiplatelet Therapy in Patients With Chronic Total Occlusion

Background Clopidogrel nonresponsiveness is a prognostic marker after percutaneous coronary intervention. Prasugrel and ticagrelor provide a better platelet inhibition and represent the first‐line ...